Like so many financial technology companies, German neobroker Nextmarkets raised capital in 2021 on a wave of optimism. Christian Angermayer, a German biotech entrepreneur with an interest in commercializing medical use of psychedelic drugs, invested alongside a group of fintech and cryptocurrency enthusiasts, including British hedge fund billionaire Alan Howard.
Jump to:
The $30 million series-B funding round was designed to propel the international expansion of Nextmarkets’ commission-free share-trading platform, making it a pan-European rival to Robinhood in the US.
Access intelligence that drives action
To unlock this research, enter your email to log in or enquire about access
